Yuanbao Inc.
YBTechnologyNASDAQSoftware - Application
Scan Results
Daily timeframeYuanbao Inc., together with its subsidiaries, provides insurance brokerage and agency licenses services in the People's Republic of China. With a market capitalization of $656.6M, it sits in small-cap territory. The company offers medical, critical illness, accident, property, and pet insurance products.
Market Cap
$656.6M
Beta
—
P/E (TTM)
3.35
P/E (Fwd)
2.90
EPS (TTM)
$4.25
EPS (Fwd)
$4.92
ROE
50.9%
ROA
22.5%
Cash
$3.96B
Total Debt
$7.9M
Free CF
$969.8M
52W Change
-5.6%
Annual Financials
Cash vs Debt
With $3.96B in cash and $7.9M in debt, YB maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company generates $969.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of 50.9% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Return on assets of 22.5% further supports the picture of efficient asset utilization. Revenue has grown from $850.2M (2022) to $4.37B (2025), reflecting a 414% increase over the period.
With cash comfortably exceeding debt, YB has financial flexibility that may help navigate uncertain periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Yuanbao Inc. and its sector.